نتایج جستجو برای: atpiii

تعداد نتایج: 320  

Journal: :Revista medica de Chile 2010
Andrea A Valenzuela Alberto Maíz Paula Margozzini Catterina Ferreccio Attilio Rigotti Ricardo Olea Antonio Arteaga

BACKGROUND There are several diagnostic criteria for Metabolic Syndrome (MS) definition. AIM To study their application in the Chilean general adult population. MATERIAL AND METHODS We analyzed data from a random sub sample of 1.833 adults aged 17 years and older surveyed during the First Chilean National Health Survey conducted in 2003. The prevalence of MS was estimated using the update A...

ژورنال: :مجله غدد درون ریز و متابولیسم ایران 0
دکتر محمود امامی میبدی m emami maybodi department of cardiology, shaheed sadoughi unviversity of medical sciences, yazd, iran. دکتر امید بیکی بندرآبادی o beiki bondar abadi department of cardiology, shaheed sadoughi unviversity of medical sciences, yazd, iran.یزد، بلوار نواب صفوی، بن بست شهید دوران، پلاک 459، کدپستی 96864-89196، دکتر امید بیکی بندرآبادی دکتر عباس اندیشمند a andishmand department of cardiology, shaheed sadoughi unviversity of medical sciences, yazd, iran. دکتر محمدرضا حاجی اسماعیلی mr haji esmaili department of cardiology, shaheed sadoughi unviversity of medical sciences, yazd, iran. دکتر مصطفی متفکر m motafakker department of cardiology, shaheed sadoughi unviversity of medical sciences, yazd, iran.

مقدمه: درمان سختگیرانه عوامل خطر بیماری عروق کرونر به عنوان علت اصلی مرگ و میر جهان امروز تأثیر کاملاً مثبتی بر جلوگیری از پیشرفت بیماری اترواسکلروتیک قلبی ـ عروقی دارد. در این مطالعه روش های درمانی دارویی انجام شده برای هیپرلیپیدمی توسط پزشکان یزد با درمان استاندارد پیشنهادی برنامه ملی آموزش کلسترول(national cholesterol education program - adult treatment panel iii) مقایسه شده است. مواد و روش ه...

توحیدی, مریم , حدایق, فرزاد , شیخ الاسلامی, فرهاد , ضابطیان, آزاده , عزیزی, فریدون ,

Background: The aim of this study was to examine the prevalence of the metabolic syndrome (MetS) and its association with coronary heart disease (CHD) in Iranian older individuals. Methods: In this cross-sectional study, the prevalence of the MetS was determined according to the Third Adult Treatment Panel (ATPIII), the World Health Organization (WHO) and the International Diabetes Federation (...

Journal: :Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2011
M F Gronner P L Bosi A M Carvalho G Casale D Contrera M A Pereira T M Diogo M T C G Torquato G M D Souza J Oishi A M O Leal

The present study estimated the prevalence of metabolic syndrome (MS) according to the criteria established by the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII) and the International Diabetes Federation (IDF) and analyzed the contribution of social factors in an adult urban population in the Southeastern region of Brazil. The sample plan was based on multistage ...

2014
Maria Auxiliadora Nogueira Saad Gilberto Perez Cardoso Wolney de Andrade Martins Luis Guillermo Coca Velarde Rubens Antunes da Cruz

BACKGROUND Metabolic syndrome (MS) is an aggregation of risk factors that increase the incidence of cardiovascular events and diabetes mellitus (DM). Population aging is accompanied by higher prevalence of MS, which varies depending on the population studied and the diagnostic criteria used. OBJECTIVE To determine prevalence of MS in the elderly using four diagnostic criteria and agreement be...

2014
Pedro Tauler Miquel Bennasar-Veny Jose M. Morales-Asencio Angel A. Lopez-Gonzalez Teofila Vicente-Herrero Joan De Pedro-Gomez Vanessa Royo Jordi Pericas-Beltran Antoni Aguilo

BACKGROUND Metabolic Syndrome (MetS) is a complex disorder defined as a cluster of interconnected risk factors such as hypertension, dyslipidemia, obesity and high blood glucose levels. Premorbid metabolic syndrome (PMetS) is defined by excluding patients with previously diagnosed cardiovascular disease or diabetes mellitus from those suffering MetS. We aimed to determine the prevalence of PMet...

2013
Dhananjay Yadav Sunil Mahajan Senthil K. Subramanian Prakash Singh Bisen Choon Hee Chung GBKS Prasad

UNLABELLED The aim of study was to determine the prevalence of metabolic syndrome (MetS) in people with type 2 diabetes mellitus (T2DM). National Cholesterol Education Program (NCEP) ATPIII Criteria, International Diabetes Federation and the World Health Organization (WHO) definitions were used in quantifying the metabolic syndrome and also the concordance between these three criteria's used fo...

Journal: :Diabetes care 2007
Carlos Lorenzo Ken Williams Kelly J Hunt Steven M Haffner

OBJECTIVE The clinical value of metabolic syndrome is uncertain. Thus, we examined cardiovascular disease (CVD) and diabetes risk prediction by the National Cholesterol Education Program (NCEP)-Adult Treatment Panel III (ATPIII), International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome. RESEARCH DESIGN AND METHODS We analyzed the risks associated ...

2012
Hui Cai Jianping Huang Guangfei Xu Zili Yang Ming Liu Yaoping Mi Weisheng Liu Hongjun Wang Derong Qian

BACKGROUND AND AIMS Metabolic syndrome (MS) is prevalent in recent years but few data is reported in the rural areas in China. The aim of this study was to examine MS prevalence and its risk factors among women in rural China. METHODS AND RESULTS The Nantong Metabolic Syndrome Study (NMSS), a population based cross-sectional study, was conducted during 2007-2008 in Nantong, China. In person i...

2014
Julie K. K. Vishram Anders Borglykke Anne H. Andreasen Jørgen Jeppesen Hans Ibsen Torben Jørgensen Luigi Palmieri Simona Giampaoli Chiara Donfrancesco Frank Kee Giuseppe Mancia Giancarlo Cesana Kari Kuulasmaa Veikko Salomaa Susana Sans Jean Ferrieres Jean Dallongeville Stefan Söderberg Dominique Arveiler Aline Wagner Hugh Tunstall-Pedoe Wojciech Drygas Michael H. Olsen

OBJECTIVE To investigate the influence of age and gender on the prevalence and cardiovascular disease (CVD) risk in Europeans presenting with the Metabolic Syndrome (MetS). METHODS Using 36 cohorts from the MORGAM-Project with baseline between 1982-1997, 69094 men and women aged 19-78 years, without known CVD, were included. During 12.2 years of follow-up, 3.7%/2.1% of men/women died due to C...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید